{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:51:37Z","timestamp":1762001497410,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T00:00:00Z","timestamp":1392076800000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Intramural Research Program"},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.ymgmr.2014.02.003","type":"journal-article","created":{"date-parts":[[2014,3,16]],"date-time":"2014-03-16T22:34:30Z","timestamp":1395009270000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria"],"prefix":"10.1016","volume":"1","author":[{"given":"Christina","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda K.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Dorward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George E.","family":"Hoganson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynne","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgmr.2014.02.003_bb0005","first-page":"1","article-title":"3-Methylglutaconic aciduria: a common biochemical marker in various syndromes with diverse clinical features","volume":"84","author":"Gunay-Aygun","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0887-8994(93)90046-F","article-title":"Multiple syndromes of 3-methylglutaconic aciduria","volume":"9","author":"Gibson","year":"1993","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10545-012-9580-0","article-title":"Inborn errors of metabolism with 3-methylglutaconic aciduria as discriminative feature: proper classification and nomenclature","volume":"36","author":"Wortmann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s10545-012-9579-6","article-title":"3-Methylglutaconic aciduria\u2014lessons from 50 genes and 977 patients","volume":"36","author":"Wortmann","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ana.410330117","article-title":"3-Methylglutaconic aciduria in \u201coptic atrophy plus\u201d","volume":"33","author":"Costeff","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0030","series-title":"GeneReviews\u2122 (www.genereviews.org)","article-title":"OPA3-related 3-methylglutaconic aciduria","author":"Gunay-Aygun","year":"1993"},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0035","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/324651","article-title":"Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews","volume":"69","author":"Anikster","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2010.03.005","article-title":"OPA3, mutated in 3-methylglutaconic aciduria type III, encodes two transcripts targeted primarily to mitochondria","volume":"100","author":"Huizing","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0045","doi-asserted-by":"crossref","first-page":"D815","DOI":"10.1093\/nar\/gkl935","article-title":"PeroxisomeDB: a database for the peroxisomal proteome, functional genomics and disease","volume":"35","author":"Schluter","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0050","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s00018-010-0365-z","article-title":"Optic atrophy 3 as a protein of the mitochondrial outer membrane induces mitochondrial fragmentation","volume":"67","author":"Ryu","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2005.07.034","article-title":"Optic atrophies in metabolic disorders","volume":"86","author":"Huizing","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0060","doi-asserted-by":"crossref","first-page":"E692","DOI":"10.1002\/humu.21025","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferre","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1096-7192(02)00047-1","article-title":"3-Methylglutaconic aciduria type III in a non-Iraqi-Jewish kindred: clinical and molecular findings","volume":"76","author":"Kleta","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0070","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1007\/s10545-008-0981-z","article-title":"Costeff optic atrophy syndrome: new clinical case and novel molecular findings","volume":"31","author":"Ho","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jamaneurol.2013.1174","article-title":"A novel OPA3 mutation revealed by exome sequencing: an example of reverse phenotyping","volume":"70","author":"Arif","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0080","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1136\/jmg.2003.016576","article-title":"OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract","volume":"41","author":"Reynier","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0035-3787(05)85075-1","article-title":"An OPA3 gene mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs","volume":"161","author":"Verny","year":"2005","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0090","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/jmedgenet-2013-101774","article-title":"A novel heterozygous OPA3 mutation located in the mitochondrial target sequence results in altered steady-state levels and fragmented mitochondrial network","volume":"50","author":"Grau","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/brain\/awm333","article-title":"A missense mutation in the murine Opa3 gene models human Costeff syndrome","volume":"131","author":"Davies","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0100","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000257426","article-title":"Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients","volume":"24","author":"Ramalho","year":"2009","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1083\/jcb.108.2.229","article-title":"The scanning model for translation: an update","volume":"108","author":"Kozak","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0110","doi-asserted-by":"crossref","first-page":"7743","DOI":"10.1074\/jbc.C200677200","article-title":"Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis","volume":"278","author":"Olichon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0115","doi-asserted-by":"crossref","first-page":"e9367","DOI":"10.1371\/journal.pone.0009367","article-title":"Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1","volume":"5","author":"Krebiehl","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0120","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1523\/JNEUROSCI.6338-11.2012","article-title":"Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration","volume":"32","author":"Misko","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0125","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.tcb.2012.10.006","article-title":"Mitochondrial dynamics in neurodegeneration","volume":"23","author":"Itoh","year":"2013","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF01955244","article-title":"Multiple respiratory chain abnormalities associated with hypertrophic cardiomyopathy and 3-methylglutaconic aciduria","volume":"152","author":"Ibel","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2014.02.003_bb0135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/088307380101600214","article-title":"Mitochondrial DNA depletion associated with partial complex II and IV deficiencies and 3-methylglutaconic aciduria","volume":"16","author":"Scaglia","year":"2001","journal-title":"J. Child Neurol."}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426914000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426914000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:48:10Z","timestamp":1762001290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426914000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":27,"alternative-id":["S2214426914000196"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2014.02.003","relation":{},"ISSN":["2214-4269"],"issn-type":[{"type":"print","value":"2214-4269"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two novel compound heterozygous mutations in OPA3 in two siblings with OPA3-related 3-methylglutaconic aciduria","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2014.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}